Suppr超能文献

德国慢性腿部溃疡的疾病经济负担。

Cost-of-illness of chronic leg ulcers in Germany.

机构信息

Health Economics and QoL Research Group, German Center for Health Services Research in Dermatology (CVderm), Department of Dermatology, University Clinics of Hamburg, Hamburg, Germany.

出版信息

Int Wound J. 2010 Apr;7(2):97-102. doi: 10.1111/j.1742-481X.2010.00660.x.

Abstract

Chronic wounds are important because of their frequency, their chronicity and high costs of treatment. However, there are few primary data on the cost-of-illness in Germany. The aim was to determine the cost-of-illness of venous leg ulcers (VLU) in Germany. Prospective cost-of-illness study was performed in 23 specialised wound centres throughout Germany. Direct, medical, non medical and indirect costs to the patient, statutory health insurers and society were documented. Thereover, health-related quality of life (QoL) was recorded as intangible costs using the Freiburg quality of life assessment for wounds (FLQA-w, Augustin). A total of 218 patients (62.1% female) were recruited consecutively. Mean age was 69.8 +/- 12.0 years. The mean total cost of the ulcer per year and patient was 9569 euros, [8658.10 euros (92%) direct and 911.20 euros (8%) indirect costs]. Of the direct costs, 7630.70 euros was accounted for by the statutory health insurance and 1027.40 euros by the patient. Major cost factors were inpatient costs, outpatient care and non drug treatments. QoL was strikingly reduced in most patients. In Germany, VLU are associated with high direct and indirect costs. As a consequence, there is a need for early and qualified disease management. Deeper-going cost-of-illness-studies and cost-benefit analyses are necessary if management of chronic wounds is to be improved.

摘要

慢性伤口很重要,因为它们的发病率高、病程长且治疗费用高。然而,德国关于疾病负担的原始数据很少。本研究旨在确定德国静脉性腿部溃疡(VLU)的疾病负担。在德国 23 个专门的伤口中心进行了前瞻性疾病负担研究。记录了患者、法定健康保险公司和社会的直接医疗费用、非医疗费用和间接费用。此外,还使用奥古斯丁伤口生活质量评估量表(FLQA-w)记录了无形的健康相关生活质量(QoL)。共连续招募了 218 名患者(62.1%为女性)。平均年龄为 69.8 +/- 12.0 岁。溃疡每年每位患者的总费用为 9569 欧元,[8658.10 欧元(92%)为直接费用,911.20 欧元(8%)为间接费用]。直接费用中,法定健康保险占 7630.70 欧元,患者自付 1027.40 欧元。主要费用因素为住院费用、门诊护理和非药物治疗。大多数患者的生活质量明显下降。在德国,VLU 与高额的直接和间接费用有关。因此,需要进行早期和有资质的疾病管理。如果要改善慢性伤口的管理,就需要进行更深入的疾病负担研究和成本效益分析。

相似文献

1
Cost-of-illness of chronic leg ulcers in Germany.德国慢性腿部溃疡的疾病经济负担。
Int Wound J. 2010 Apr;7(2):97-102. doi: 10.1111/j.1742-481X.2010.00660.x.
2
Cost-of-illness of leg ulcers in the community.社区中腿部溃疡的疾病成本。
Int Wound J. 2014 Jun;11(3):283-92. doi: 10.1111/j.1742-481X.2012.01089.x. Epub 2012 Oct 1.
4
Burden of venous leg ulcers in the United States.美国下肢静脉溃疡的负担。
J Med Econ. 2014 May;17(5):347-56. doi: 10.3111/13696998.2014.903258. Epub 2014 Mar 24.
5
Measuring costs and quality of life for venous leg ulcers.测量静脉性下肢溃疡的成本和生活质量。
Int Wound J. 2019 Feb;16(1):112-121. doi: 10.1111/iwj.13000. Epub 2018 Oct 5.
9
Cost-of-illness of patients with lymphoedema.淋巴水肿患者的疾病经济负担。
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1930-1935. doi: 10.1111/jdv.14442. Epub 2017 Oct 10.
10
Treatment of venous leg ulcers using bilayered living cellular construct.双层活细胞构建物治疗静脉性腿部溃疡。
J Comp Eff Res. 2020 Sep;9(13):907-918. doi: 10.2217/cer-2020-0076. Epub 2020 Sep 24.

引用本文的文献

6
No More Venous Ulcers-What More Can We Do?告别静脉溃疡——我们还能做些什么?
J Clin Med. 2023 Sep 23;12(19):6153. doi: 10.3390/jcm12196153.
8
Endovenous ablation for venous leg ulcers.静脉内消融治疗静脉性腿部溃疡。
Cochrane Database Syst Rev. 2023 Jul 27;7(7):CD009494. doi: 10.1002/14651858.CD009494.pub3.

本文引用的文献

3
[Cost of illness studies as a basis for decision making].[疾病成本研究作为决策依据]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 Jan;49(1):19-27. doi: 10.1007/s00103-005-1191-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验